CPHI | tickerfilter.com

Fundamental analysis

14%

Profitability 0%

Dept financing 16%

Liquidity 45%

Performance 20%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-45.56%

1 Month

-43.48%

3 Months

-38.42%

6 Months

-45.86%

1 Year

-63.31%

2 Year

-92.35%

Key data

Stock price

$0.13

P/E Ratio

0.00

DAY RANGE

$0.12 - $0.19

EPS

N/A

52 WEEK RANGE

$0.12 - $0.41

52 WEEK CHANGE

-$65.79

MARKET CAP

4.056 M

YIELD

N/A

SHARES OUTSTANDING

17.163 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

04-15-2025

BETA

1.35

PUBLIC FLOAT

AVERAGE 10 VOLUME

$606,457

AVERAGE 30 VOLUME

$652,378

Company detail

CEO: Zhi L. Li
Region: US
Website: chinapharmaholdings.com
Employees: 250
IPO year: 2002

Issue type: Common Stock
Market: NYSE American
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain.

CPHI - CHINA PHARMA HOLDINGS, INC.